Clinical Trials Browser

Sarcoma × regorafenib × 90 days × Clear all

NCT03793361 2026-03-18

EREMISS

Phase 2 Completed

Sarcoma

NCT01900743 2026-03-13

REGO-SARC

Phase 2 Completed

Neoplasm Metastasis, Sarcoma